NEOPLASM RECURRENCE, LOCAL
Clinical trials for NEOPLASM RECURRENCE, LOCAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM RECURRENCE, LOCAL trials appear
Sign up with your email to follow new studies for NEOPLASM RECURRENCE, LOCAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 4-Week radiation course be as good as 5 weeks for prostate cancer?
Disease control Recruiting nowThis study compares two radiotherapy schedules for men whose prostate cancer has returned after surgery. The standard treatment takes 5 weeks, while the shorter one takes 4 weeks. Researchers want to see if the shorter schedule causes no more side effects and controls the cancer …
Matched conditions: NEOPLASM RECURRENCE, LOCAL
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New hope for recurrent endometrial cancer: drug combo shows promise
Disease control Recruiting nowThis study is for people with endometrial cancer that has come back or spread to a few other spots. It tests a new drug called cadonilimab given together with standard chemotherapy and radiation. The goal is to see if this combination can shrink tumors and help people live longer…
Matched conditions: NEOPLASM RECURRENCE, LOCAL
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cocktail of cancer drugs targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis early-stage trial is testing a new three-drug combination for people with head and neck cancer that has come back or spread. The drugs include a targeted therapy (zanzalintinib), an immunotherapy (pembrolizumab), and another targeted antibody (cetuximab). The main goal is to…
Matched conditions: NEOPLASM RECURRENCE, LOCAL
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC